Press release
Verastem Oncology Announces Andrei Shustov, M.D., Recipient of 2nd Annual Innovation in Care Award
BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (Nasdaq: VSTM), (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and
About this update from Verastem, Inc.
[{"type":"text","content":" BOSTON--(BUSINESS WIRE)--\nVerastem, Inc. (Nasdaq: VSTM), (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced that Andrei Shustov, M.D., Professor of Medicine and Hematology, University of Washington, Associate Member, Clinical Research Division, Fred Hutchinson Cancer Research Center and President and Founder of the T-Cell Leukemia and Lymphoma Foundation (TCLLF) has been selected to receive the Company’s Innovation in Care Award.\n\n\nThe Verastem Oncology Innovation in Care Award recognizes individuals, organizations or teams who are leading the way in advancing the principles of patient-focused care, including coordination and integration of care, engaging patients, families, and caregivers in providing comprehensive support as well as collaborating with others in the cancer care system for ongoing quality improvement.\n\n\n“Recognizing a critical lack of resources available to those affected by T-cell leukemias and lymphomas, Dr. Shustov has dedicated his career to breaking new ground to expand support and research efforts to those affected by these diseases,” said Brian Stuglik, Chief Executive Officer of Verastem Oncology. “As a company, we aim to follow the example of leaders like Dr. Shustov as we not only seek to deliver therapies that keep cancer at bay, but also continually look to innovate to improve the lives of those diagnosed with cancer.”\n\n\nThe TCLLF is committed to providing reliable, accurate and quality resources to patients, family members, caregivers and medical professionals looking to learn more about T-cell leukemias and lymphomas. Its patient education forums give direct access to T-cell leukemia/lymphoma specialists, which allows them the opportunity to learn more about their specific disease and ask personalized questions. The Foundation has also recently started sponsoring an annual T-Cell Leukemia/Lymphoma Young Investigator Grant with the goal of producing valuable research efforts and encouraging new oncologists/hematologists to specialize in the treatment of these diseases.\n\n\n“Patients and their families affected by rare lymphoid malignancies like T-cell lymphomas have very limited resources available to them to learn about their disease an...